Quest Diagnostics' Q4 revenue beats estimates, raises dividend

Quest Diagnostics

10/02/2026 11:55

Overview

Diagnostic services provider's Q4 revenue rose 7.1%, beating analyst expectations

Adjusted EPS for Q4 beat analyst expectations

Company increased quarterly dividend by 7.5% to $0.86 per share

Outlook

Quest Diagnostics expects 2026 revenue between $11.70 bln and $11.82 bln

Company forecasts 2026 adjusted diluted EPS between $10.50 and $10.70

Quest Diagnostics anticipates 2026 cash from operations around $1.75 bln

Result Drivers

STRATEGIC COLLABORATIONS - Quest Diagnostics highlighted strategic collaborations, including a joint venture with Corewell Health and partnerships with Epic and Fresenius Medical Care, as key drivers of growth

CONSUMER TESTING EXPANSION - The company expanded its consumer-initiated test platform, questhealth.com, adding new tests and collaborations with wellness companies

CLINICAL INNOVATIONS - Quest Diagnostics introduced new diagnostic tests, including the Quest AD-Detect blood test for Alzheimer's and the Haystack MRD test for cancer monitoring

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q4 Revenue
Beat
$2.81 bln
$2.75 bln (14 Analysts)
Q4 Adjusted EPS
Beat
$2.42
$2.36 (16 Analysts)
Q4 EPS
$2.18
Q4 Net Income
$245 mln


Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 10 "strong buy" or "buy", 10 "hold" and no "sell" or "strong sell"

The average consensus recommendation for the healthcare facilities & services peer group is "buy"

Wall Street's median 12-month price target for Quest Diagnostics Inc is $203.00, about 6.1% above its February 9 closing price of $191.25

The stock recently traded at 18 times the next 12-month earnings vs. a P/E of 17 three months ago

Press Release: ID:nPn22Smbsa

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)